In December, the U.S.-based National Academy of Sciences published a report classifying myopia, for the first time, as a ...

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large ...

Paediatric ophthalmologist, Dr Katie Williams, discusses her research exploring factors associated with myopia ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

High levels of exposure to air pollution can increase the incidence of diabetic retinopathy and glaucoma, a recent study ...

Sydnexis, Inc. ( a pre-commercial stage biopharmaceutical company, today announced that the U.S. Food and Drug Administration ...

What started as a scholarly study becomes, in Will Rees’s hands, a freewheeling journey into our brains and souls.

The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

Glaucoma is an eye disease that mostly affects older adults However it can also affect young individuals Read to learn about ...

An analysis of data from more than 100 studies and 17,000 children has questioned the effectiveness of myopia management ...

The Vietnam Eye Care Market was valued at USD 40.71 million in 2024 and is projected to experience steady growth with a compound annual growth rate (CAGR) of 5.23% through 2033. This market expansion ...